Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 13, 2008
Provides valuable insights for diabetic patients, who are often at higher risk for adverse events and repeat stenting procedures
-
May 13, 2008
Boston Scientific welcomed two-year results from the SPIRIT III clinical trial, presented at the 2008 EuroPCR Scientific Program in Barcelona.
-
May 13, 2008
Company supports efforts of International Diabetes Federation to promote worldwide diabetes care and prevention
-
May 8, 2008
"We are very pleased with the decision by the Canadian Federal Court dismissing this case," said Boston Scientific's Chief Operating Officer.
-
May 8, 2008
ALTRUA™ is Company's most advanced pacemaker and delivers enhanced therapies while maintaining its small size and battery longevity.
-
May 7, 2008Boston Scientific Announces European Approval and Market Launch of New Family of Advanced Pacemakers
Boston Scientific Corporation (NYSE: BSX) today announced CE Mark approval and market launch of its ALTRUA™ family of pacemakers. ALTRUA is Boston...
-
May 5, 2008
Ruling from World Intellectual Property Organization (WIPO) arbitration panel finds no infringement
-
Apr 30, 2008
A live webcast and replay of the May 6 conference session will be available
-
Apr 24, 2008
A live webcast and replay of the April 30 session will be available.
-
Apr 24, 2008
MADIT-CRT trial designed to test whether CRT-Ds can slow the progression of heart failure in heart attack survivors